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ABSTRACT  
Microsponges are particulate system which is composed by porous polymeric material. As compare to Conventional topical formulations, 
microsponge provide controlled release of the drug in the epidermis, it is to ensure that the drug is mainly localized and does not undul y 
entering the systemic circulation, it is a new area of research. The active ingredient needs to maximize the time to stay on the skin, while 
reducing transdermal penetration. Apart from this, there is a problem of unethical vehicles that can be viscous sticky deformation and skin 
irritation.  One of the biggest challenges of now a days is to control irritability for a predetermined site of active agents in the human body. 
Microsponges delivery system is a unique technique for controlled release with low irritant involving many triggers of Mechanism for the 
release of drugs. The Microsponge Delivery system is a polymeric porous microspheres, which can trap a wide range of effective elements such 
as anti-fungus, anti-infected, anti- inflammatory agent, fragrance and essential agent. This review includes different techniques used to prepare 
microsponges, formulation consideration, safety consideration, drug release mechanism, and challenges with microsponge drug delivery 
system along with their advantages, disadvantages and applications. In the current review, we summarize the updated application and capacity 
of Microsponge as an effective drug-delivery system to reduce skin irritation. 
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1. INTRODUCTION 
All conventional topical formulations are work on the outer 
layers of the skin. When the active ingredients of these 
formulations are released after application, an extremely 
concentrated layer of active ingredient is fashioned, that is 
speedily absorbed. Thus, there is a rightful require for drug 
delivery systems to prolong the time so that active 
ingredients can be retained on the surface of the skin or 
abandoning transdermal penetration within epidermis. In 
addition, as a result of high concentration of active agents in 
traditional topical dosage forms, many side effects are 
recorded such as irritation and allergic reactions [1]. The 
additional potential limitation of topical conventional 
formulations is uncontrolled evaporation of the active 
ingredient, unethical vehicles that are sleek, sticky and 
discoloration, and drugs may be cause the discrepancy with 
vehicles. This reduces the compliance of patients' treatment 
[2]. One of the biggest challenges for pharmaceutical science 
is to control the distribution rate of active ingredients in a 
human body on a predetermined site, to control the release 
of the drug in epidermis, ensuring that the drug is mostly 
localized and does not enter unnecessarily in systemic 
circulation, [3]. The scenario of drug delivery technology has 
become very enthusiastic and is developing rapidly. The 
greater development in the delivery system is being 
integrated to optimize the effectiveness and cost 
effectiveness of the medicine [4].  In the last few years, there 
has been a significant growth in the number of products 
based on the new drug delivery system, for improving safety, 
efficacy and patient compliance has been achieved by 
incorporating an existing drug into a new drug delivery 
system [5]. 
Carrier technologies are a possible solution to these 
challenges. Microparticles and nanoparticles have been 
researched rapidly for targeted and continuous elease of 
drugs. It includes microspheres, liposomes, and nanopactics, 
which modify the absorption and release characteristics of 
drugs. Microspheres are unable to control the drug's release 
rate manually. Once the outer wall is broken, the drug 
contained in Microspheres will exit from it [6]. In liposomes, 
fluttering of lesser drugs, difficulty in preparing deformities, 
limited chemical stability and microbial stability worsens, 
hence the need of the preservatives. In solid lipid 
nanoparticles, there are more benefits in topical drug 
delivery. Nanomaterial can easily enter systemic circulation 
by inhalation or injection, and probably through skin 
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absorption, especially if the skin is damaged [7]. Only once in 
the bloodstream, nanomaterials can be taken almost in the 
body and taken by the limbs and tissues including the brain, 
heart, liver, kidney, spleen, bone marrow and nervous 
system. Micro-sponge-based polymeric microsphere helps 
overcome problems related to superior technologies. 
Compared to conventional method, the microscope system 
can stop epidermis and excessive accumulation of material 
within the skin [8]. Furthermore, the MDS can reduce the 
irritation of skin irritating drug without reducing the 
effectiveness of the system. For example, MDS-benzoyl 
peroxide formulations have a minimal irritation by gradually 
delivering the active ingredient to the skin [9]. 
2. MICROSPONGES DELIVERY SYSTEM (MDS) 
2.1 Overview of microsponges 
Microsponges Delivery System (MDS) is porous, cross-
linked, polymeric microspheres, polymeric systems, which 
include porous microsphere, which can entangle a wide 
range of drug and then release them into skin at one time 
and in response to trigger”. Microsponges technology was 
developed In 1987, Won pioneered microsponge system 
(MDS) technology, These patents include Advanced Polymer 
Systems, Inc. (United States) [10]. Microsponges are small 
sponges, like circular particles, in which there is no 
processed structure with a large cough surface through 
which the active ingredient is released in a controlled 
manner. The size of the microscope ranges from 5-300µm in 
diameter and in a specific 25μm area, the spacing of up to 
250000 pores  and an internal pore structure can be equal to 
10 feet length, making it almost 1ml / gram for all embracing 
drug retention. The surface can be separated from 0.1 to 0.3 
centimeters / grams in quantity of 20 to 500 m / g and 2 
pore [11]. 
The Scanning electron microscopy of microsponge particles 
shows that its internal structure is "bag of marbles". It is a 
unique technique for controlling release of topicall agents, in 
which microporous pearls are normally 10-25 microns in 
diameter, loaded with active ingredients, which in turn 
result in them in a controlled manner into the skin at a time, 
including triggers rubbing, pH, friction moisture and 
ambient skin temperature [9]. When it is applied to the skin, 
drug release can be controlled through spread. This 
controlled release of active ingredient on the skin at the time 
has been done to provide enhanced product efficacy, 
tolerance, benignity benefits, and to reduce the irritability 
associated with powerful therapeutic agents such as retinoid 
or benzyl peroxide and the range of a comprehensive skin 
therapies [12]. 
 
 
Fig 1: Structure of Microsponge 
Microsponges have the ability to absorb or load high volume 
of active ingredients on the particle or its surface. 
Microsponges separate from other types of dermatology 
delivery systems, the ability to be active to activate its 
intensity up to 3 times. In the distinction, Micro-sponge 
technology allows a flat and constant rate of release, which 
reduces irritation in maintaining efficacy. Microsponges are 
able to absorb the secretion of the skin, so the skin glows 
down and shines from the skin [12]. MDS can prevent 
accumulation of ingredients within the skin. Potentially, they 
can reduce the irritation of skin irritating drugs, without 
reducing their efficacy [13]. Another advantage is the 
potential bacterial contamination of the material entrapped 
in the microsponge since the size of the pore diameter is 
lighter, the bacteria from 0.007 to 0.2 microns cannot 
penetrate into the digging structure of the 
microsponges[12].  Due to the trapping of drug molecules 
within the microscopic holes, the rate of solubilization of 
poorly water-soluble drug becomes improved. When the 
drug molecules are trapped in the pores, then the particle 
size is shortened due to the small aperture size (~ 0.07-0.25 
μm). As the particle size decreases, its surface area increases, 
which leads to increased drug solubility [14]. 
Micro-sponge drug delivery technology is far and wide for 
dermatology drug delivery products. But Micro-sponges 
drug delivery also extends its application in oral drug 
delivery, bone and tissue engineering in the investigation of 
illness and RNAi silencing [15]. 
Recent applications from Microsponges obtained from 
seaweed can help in the diagnosis of cardiovascular disease, 
cancer, HIV and other diseases, and a lot less cost than 
current diagnostic methods. Biomarkers are hidden in small 
sponges set in an array of pyramid-shaped funnels in the 
heart of the PBNC microprocessor, which is in the shape of a 
credit card [16]. 
Nowadays, many Food and Drug Administration (FDA) - 
approved products such as Retin-A Micro® (0.1 or 0.04% 
tretinoin) and Carac (0.5% 5- flurouracil) are used for acne 
treatment and actinic keratos [17].  
2.2 Potential feature of Microsponges drug 
delivery system [18, 19]. 
 MDS are unbreakable on the range of pH 1-11. 
 They are mostly affiliates with vehicles and excipients. 
 Microsponges have increased the efficiency of trapping 
by 50 to 60%. 
 They flow freely and are cost effective and have more 
sense of flexibility. 
 Due to self-sterility, their average pore size is around 
0.25 microns, while bacteria cannot Infiltration in the 
pores. 
 These particles are deployed in the shape of the skin 
absorbing.  
 Microsponges are microscopic spheres able to absorb 
skin secretion, therefore, to reduce oiliness and shine 
with skin. 
 Microsponges formulation can absorb 6 times the 
weight of oil without drying. 
 It provides 12 hours of continuous action, i.e. extended 
release. 
 Microsponges are non-allergic, non-irritating, non-
metagenic and non-toxic. 
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Microsponges particles themselves are very large, so they 
are complex to absorb in the skin and this protects these 
Microsponges materials by avoiding the side effects 
microsponges adjutants. Microsponges formulations can 
also be cost effective for the use of cosmetic mass market 
where the cost of materials is important [20]. Inequalities 
for other technologies like microencapsulation and 
liposomes, chemical stability in MDS, a wide range of high 
payloads and easy to prepare [21]. 
 
 
2.3 Advantages of microsponge delivery systems [16, 22, and 23]. 
Table 1: Advantages of microsponge delivery systems 
S.No Advantages Comments 
1. High Surface Area The total pore length of approximately 10 feet in 25μ sphere can be around 1 mg / gram 
with the amount of quantity and can have up to 25,000 pore. It provides a broad surface 
area to trap high. 
2. Range Microsponges can be prepared to regulate their properties and make them suitable for an 
accurate purpose. Various parameters can be converted into which particle size, pore 
characteristics and hardness are included. 
3. Simple Production 
Methodology 
Production of such Microsponges is comparatively simple in scaling up and therefore has 
an advanced capacity for commercialization. 
4. Programmable Release Pressure Triggered Systems 
Temperature Triggered Systems 
pH Triggered Systems 
Solubility Triggered Systems 
5. Safety of microsponges Most of the polymers used in formulation are inactive and inability to cross through 
stratum corneum, their inability to increase their safety, apart from this, reduces the 
irritation of various actives and thus indicates its harmlessness. 
 
Table 2: - Advantages of Microsponges over Other Formulations 
S.No  Advantages Other Formulations Microsponges formulation 
1. Advantages over 
Conventional 
Formulations 
Conventional formulation actively produce a 
highly concentrated layer of active ingredient, 
which are rapidly absorbed. 
MDS can prevent excessive accumulation 
of drugs within the skin. Potentially, the 
MDS can reduce the irritation of skin 
irritating active ingredient without 
significantly reducing their efficacy [9]s. 
2. Advantages over 
Microencapsulation 
and Liposomes 
Microcapsules cannot do more often than 
controlling the release rate of activation. Once the 
wall is broken the activations contained within the 
microcapsules will be unconstrained. 
In the inequality for Microencapsulation 
and Liposomes system, the 
Microsponges system prevents these 
limitations [9, 24]. 
3. Advantages over 
Ointments 
Ointments are often invisible, sleek and sticky 
from aesthetics, which often occur in lack of 
patient adherence. These vehicles require high 
concentrations of active agents for effective 
treatment because their delivery system has less 
efficiency, causing significant users to have 
irritation and allergic reactions. 
The microscope system increases the 
maximum amount of time, which is an 
active ingredient on the skin surface or 
in epidermis, while reducing its 
transdermal penetration in the body [12, 
25]. 
 
2.4 Category of drugs Explored in microsponges 
delivery system [26]. 
 Anti-Inflammatory 
 Anti Fungals 
 Anti-Acne 
 Anti-Dandruffs 
 Skin Depigmenting Agnts 
 Sunscreens 
 Antipruritics 
 Rubefacients 
2.5 Drug release mechanism of microsponges 
Microsponges contain a large amount of porous 
microspheres, which have a complex network of 
interconnection with a non-compressed structure. The active 
ingredient is added to the trapped form in the vehicle. Once 
formulation is applied to the preferred area of the skin, the 
active ingredient spreads out of the spheres into vehicles and 
then on the skin, reduces the vehicle, which becomes 
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unsaturated, therefore, disturb the equilibrium. It will start 
the flow of particle from the micro-sponge into the vehicle, 
and from it to the skin, until the vehicle is dry or absorbed 
[12]. Even then, microsponge particles retaining to the 
surface of the stratum cornem will continue to activate the 
skin gradually, which will release over time for a long time. 
This proposed mechanism of action demonstrates the 
importance of building vehicles to trap micro-sponges. If the 
active product is very soluble in their favorite vehicle during 
preparation, then the products will not get the desired 
benefits of release [12]. As a replacement, they will behave as 
active microsponge may intend to release active elements in 
quantity over time, in response to one or more of the 
following external triggers added in the vehicle in an open 
form. Pressure, temperature change and solubility etc [4].
 
 
 
Fig: 2 Drug release from microsponge 
2.5.1 Release triggers [14]. 
The release trigger is defined as a mechanism, which can be used to release or accelerate active agents from MDS. These 
mechanisms are given below: 
 
Table 3: Drug release mechanism of microsponge 
S.No Release triggers Drug release mechanism 
1. Pressure triggered systems Rubbing or pressure is applied to the active ingredient can release from the 
microsponges into the skin. 
2. pH triggered systems The coating on microsponges can be modified by triggering the pH-based 
release of activation. 
3. Temperature change triggered systems At room temperature, some trapped active ingredients can be viscous to the 
sudden flow of the skin from the microsponges. 
4. Solubility triggered systems Microsponges loaded with water-sweeping materials such as antiseptics and 
antipersprinters will issue components in the presence of Warter. 
 
2.6 Formulation considerations 
Action taken in microsponges drug distribution system can 
then be included in many products like as lotions, creams, 
soaps and powders. While preparing the vehicle, certain 
ideas are taken into consideration to achieve the selected 
product characteristics. Solubility of the active ingredients in 
the vehicle should be limited. If not the vehicle will reduce 
the activity of microsponges before the application [9]. To 
avoid cosmetic problems; in the vehicle more than 10% to 
12% w / w microsponges should not be included. For active 
microsponges polymer designs and payloads should be 
optimized for the required release rate for the given time. 
When preparing suitable vehicles for a given application, 
some ideas should be kept in mind to achieve the desired 
product characteristics [27]. 
To prevent cosmetic problems, the powder load should be 
sufficient (not more than 10-12%) in the vehicle [28]. 
 The solubility of the active agent in the vehicle should 
be restricted; otherwise, the skin will actually reduce 
the polymer before it is applied to the skin. 
 Polymer design and loading levels should be properly 
selected for the release of active agent during the given 
period. 
2.7 Characteristics of materials that are entrapped 
in Microsponges [2, 29, 30] 
 The materials should be erased in water or should be 
slightly soluble. 
 The material must be not react with monomers and 
should maintain the viscosity of the mixture during 
preparation. 
 In Monomar, the material should be fully Egyptian, as 
well as the miscible with small amounts of water, 
besides the immiscible solvent. 
 The material should not break the spherical structure 
of the microsponges. 
 Polymerization catalyst as well as in the conditions of 
polymerization, the material should remain constant. 
 The active ingredient is trapped in microsponge then 
such products can be included in many products such 
as cream, gels, powder, lotions and soap. 
 To avoid cosmetic problems, the solubility of activators 
in the vehicle should be limited; in the vehicle more 
than 10% to 12% w / w microsponges should not be 
included. Otherwise the vehicle will reduce 
microsponges before the application. 
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 Microsponges payloads and polymer designs should be 
optimized for the required release rate for the given 
period. 
2.8 Safety considerations  
Microsponge systems are made of famous used polymers 
with very low amounts of outstanding monomers, in 
addition, the high degree of cross-linking biologically 
disables them, as the body cannot biodegrade to reproduce 
them in other substances [31]. Animal statistics show that, 
after injection into the skin, MDS does not respond to any 
swelling by the body in response to its presence. Due to their 
size, these microspheres are very large, which pass through 
the stratum corneum. They are staying behind the surface of 
the skin, gradually releasing their material over time. This 
release pattern prevents excessive accumulation of active 
agents in epidermis and as a result, can increase the safety of 
topical drugs [32]. 
2.9 Method of Microsponges preparation 
In the microsponges the drug loading can be done in two 
ways with one or two-stage process; for loading on the basis 
of physical-chemical properties of the drug [33]. If the drug 
is usually an inactive non-polar material, then it makes the 
porous structure fashionable, which is called porogen. 
Porogen drug, which neither interrupts polymerization nor 
activates it and stable for free radicals is entrapped with 
one-step process [9, 34]. 
2.10. Liquid-liquid suspension polymerization 
The liquid-liquid suspension polymerization method is 
easily method for preparation of microsponges (one-step 
process). Polymerization done in the round bottom flask of 
styrene or methyl methacrylate. In their preparation, Non-
polar active ingredients are dissolved with monomer in a 
suitable solvent immediately possible and then dispersed in 
aqueous phase this includes additives such as surfactant, 
suspended agents, etc. assistance in the formation of 
suspension. Once identified with the different droplets of the 
desired size after the suspension, polymerization is activated 
by monomer stimulant or increased temperature or 
radiation [35]. 
The various steps of microsponges preparation are 
summarized as follows: [36]. 
 Monomer selection or monomer combination. 
 Monomer chain formation as polymerization begins. 
 Ladders formations as a result of cross linking between 
chain monomers. 
 Monomer ladder folding to form spherical particles. 
 Microspheres agglomeration, which give rise to 
formation of bunches of microspheres. 
 Microspheres bunch binding to form microsponges. 
[37]. 
In some cases, an inactive liquid with water is invisible, but 
it is used to create pore network during the completely 
erosable environment with monomers. After the conclusion 
of polymerization, the fluid is released to the porous 
microspheres, that is, the microsponge. Regression within 
the preformed microsponges, then include functional 
substances [25]. 
Advantages: For drug loading one-step or two-step 
methods can be modified appropriately. 
Disadvantages: Possible trapping of unreacted monomers 
and solvent traces, monomers require long time to react to 
non-uniform structure; requires two-step methods for 
thermodynamic sensitive drugs require less drug-loading 
capability. 
2.10.1. Quasi-emulsion solvent diffusion 
In quasi-emulsion solvent diffusion method (two steps 
process), of microsponges formulation an internal phase is 
used containing polymer such as eudragit RS100, which is 
dissolved in ethyl alcohol and external phase include 
polyvinyl alcohol and distilled water [38]. 
Different steps have been summarized in the preparation of 
microsponges by quasi-emulsion solvent diffusion method: 
[24]. 
 The internal phase which containing polymer such as 
eudragit RS 100 dissolved in ethyl alcohol. 
 The drug is gradually added to internal phase (polymer 
solution) then dissolved under ultrasonication at 35ºC 
and added plasticizer such as triethylcitrate (TEC) in 
order to aid the plasticity. 
 The external phase which containing polyvinyl alcohol 
dissolved in distilled water. 
 The internal phase is then poured into external phase 
(polyvinyl alcohol and distilled water) with continuous 
stirring for 2 hours. 
 Then, separate the microsponges after mixture filtered. 
 The microsponges washed and dried in an air heated 
oven at 40°C for 12 hr [37]. 
Advantages:  No monomer entrapment, Low solvent traces, 
High drug loading, No exposure of drug to ambient 
condition, Size of microsponges can be easily controlled by 
controlling the stirring, Spherical particles. 
Disadvantages: Probable entrapment of unreacted 
monomers and solvent traces, Non uniform structure, 
requires a long time for the reaction of monomers, requires 
two-step method for thermo sensitive drugs that has low 
drug-loading efficiency. 
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Table 4: Characterization parameters of microsponges: 
Characterization 
parameter 
Methods Remarks 
Particle size 
determination of 
microsponges 
Microscopy diffractometry method used for Particle size 
analysis of loaded and unloaded microsponges. To study 
the effect of particle size on drug release, cumulative 
percentage drugs should be issued from time to time with 
various particle size microsponges. 
For all formulations, the value of 50% 
size can be used as the mean size range 
[20]. 
Morphology  of 
microsponges 
Internal and external morphology can be studied by 
scanning electron microscopy (SEM). 
The prepared microsponges are coated 
with gold-palladium under the argon 
atmosphere at room temperature and 
then studied [39]. 
Production yield of 
microsponges 
Production yield of micro particle can certainly be 
achieved by calculating the initial weight of raw material 
and can be done based on the final weight of the 
microsponges obtained. 
Production yield = [Practical mass of 
microsponges/Theoretical mass 
(polymer + drug)] × 100 [40]. 
Entrapment efficiency 
of microsponges 
Loading efficiency of drug 
determine by Drug extraction 
Method. 
Entrapment efficiency (%) = 
[Actual drug content/Theoretical 
Drug content] × 100 [41]. 
Pore structure of 
microsponges 
For controlling the power and duration of the 
effectiveness of the active ingredient the pore volume and 
diameter are important. The pore diameter affects the 
active component of the micro-sponge in the vehicle in 
which the material is dispersed. Mercury intrusion can be 
employed to study the effect of pore diameter and 
quantity with drug release rate from porosimetry 
microsponges. 
Pore structure is determined by 
Using Washburn [42]. 
Resiliency of 
microsponges 
According to the requirements of the final formulation, 
the flexibility of microsponges can be modified to produce 
soft or firmer beadlets. The rise in cross-linking reduces 
the rate of release. 
No optimized method has been 
developed to determine the 
Resiliency of the micro particles [43]. 
Drug content of 
microsponges 
Drug content in microsponges 
determine by Drug extraction 
Method. 
These carriers have better drug 
loading, thus they provide better drug 
content [44]. 
Drug release study of 
microsponges 
Drug release study in microsponges determine by USP 
apparatus II. 
When studied for oral use, the rotation 
speed is 100 rpm; Temperature is 
maintained at 37 ± 0.5 ° C on various 
physical pH for a fixed time period [45]. 
 
2.11 Applications of microsponges system 
Microsponges are mostly used for topical delivery and are 
used for oral and simultaneous biopharmaceutical delivery. 
Many patents have reported that due to its high loading 
capacity and continuous release capacity it can be used as an 
excipient. This formulation offers many options for 
developing pharmaceutical and cosmetic products [12]. 
Microsponges are deliberately able to give a drug active 
ingredient in a minimal amount efficiently and increase 
stability, reduce side effects, and modify drug releases. Over-
the-counter products that include the micro-sponge drug 
delivery system include many moisturizers, special 
renaissance products and sunscreens [25]. 
2.11.1 Microsponge for topical delivery 
The purpose of topical formulations is to provide drug to the 
outer layers of the skin. Conventional topical formulations 
producing an extremely concentrated layer of active 
ingredient in skin that is speedily absorbed [12]. However, 
microsponge systems are deliberately able to efficiently 
deliver a drug active ingredient on a minimum dose. They 
consist of non-organized structures with porous surfaces 
through which active content is released in a controlled 
manner. Therefore, such systems can avert unwarranted 
accumulation of active ingredients within the epidermis and 
the dermis, thus they can show that reducing irritation and 
side effects due to drugs without reducing their efficacy 
decreases [13]. In addition to improving drug release and 
side effects, microsponges is also capable of increasing the 
stability of many drugs. The drug loaded porous 
microsponges can be further is incorporated into cream, 
lotions or powder. Microsponges are used for the topical 
delivery of many drugs and cosmetic agents [15]. In product 
or market placements, product uses topical microsponges 
system in three primary ways: [46, 24, and 47]. 
 As closed containers investment ingredients away 
from the skin for superficial action. 
 As reservoirs releasing active ingredients over an 
extensive period of time. 
 As receptacles for absorbing uninvited substances, 
such as more skin oils.
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Table 5: Microsponge formulation 
Drugs Comments 
Dicyclomine Eudragit based microsponges were prepared by using a qusi-emulsion solvent diffusion method, 
filled with Dicyclomine. The cumulative release for microsponges for more than 8 hours ranged 
from 59 to 86%. 
Flurbiprofen Microsponge system containing flurbiprofen was formulated for the colonic delivery of the drug for 
targeted action [26]. 
Benzylperoxide BPO loaded Ethyl cellulose MDS was prepared which was capable to release of BPO into the skin. 
And it has been shown that the BPO can reduce the effect of controlled release on the skin from the 
delivery system, while percutaneous absorption can be reduced. 
Fluocinolone acetonide FA entrapped micro porous micro particles (microsponges) were formulated to control the release 
of drug to the skin, which reduces the skin irritation and produce controlled release of active 
medicament [26.] 
Hydroquinone (HQ) HQ 4% with retinol 0.15% entrapped in microsponge reservoirs was developed for the treatment of 
melasma and PIH. Microsponges were used to release HQ gradually to prolong exposure to 
treatment and to minimize skin irritation [12]. 
Aceclofenac Aceclofenac loaded microsponge are prepared by using quasiemulsion solvent diffusion method. It 
is incorporated in gel base and various parameters are studied. 
 
 
2.11.2 Microsponge Technology in Cosmetics 
An exciting application of microsponge technology can be 
found in oral cosmetics, such as as to sustain the release of 
volatile ingredients, thus increasing the duration of the 
'fresh feel'. Microsponges of such volatile ingredients may be 
effortlessly incorporated in tooth pastes or mouthwashes 
[36]. Microsponges may be used in a variety of coloured 
cosmetic products such as rouge or lipsticks to make them 
long lasting by using colour entrapment in microsponge. As 
mentioned above, Microsponges helps in dismantling 
uniforms and improves covering power. Thus, the colorful 
cosmetics prepared with microsponges will be very elegant 
[48]. 
Marketed formulation using MDS include skin products that 
can absorb large amounts of excess of skin oil from the 
surface of the skin, while the skin looks beautiful on the 
surface. These products include condioners, skin cleansing, 
moisturizers, oil control lotions, razor, deodorant, lipsticks, 
powder, makeup, and eye shadow; Which provides many 
advantages, including improved chemical and physical 
stability, better available concentrations, controlled release 
of active ingredients, brief skin irritation and sensitization, 
and exclusive touch properties [49]. 
2.11.3 Microsponge for oral delivery 
In oral applications, the MDS has been shown to increase the 
rate of solubilization of the system of poorly soluble drugs 
by trapping in such drugs in pores. Since this pore is very 
small, particles are influenced in drug and a significant 
increase in surface area thus increases the rate of many 
solubilizations [50]. It has been shown that the 
microsponges system enhances the solubilization of drugs, 
which are poorly soluble in trapping these drugs in these 
pores [51].  
A microsponges system gives many benefits for oral drug 
delivery, such as: 
 Protect active ingredients in a limited environment and 
provide oral controlled delivery in the lower part of the 
gastrointestinal tract (GIT). 
 Microsponges systems raise the solubility of poorly 
soluble drug by trapping these drugs in these porous 
structures. 
 Since the porous structure of the microsponge is very 
small in size, the trapping drugs are dense for the 
micro particles with high surface area, and as a result, 
the rate of solubilization improves. 
 Maximize the amount of drugs that are absorbed, as 
long as the microsponges system moves through the 
intestine to increase significantly. 
2.11.4 Microsponges in biopharmaceuticals delivery 
MDS is employed for both in tissue engineering as well as 
the delivery of biopharmaceuticals. Collagen microsponges 
have been studied with biodegradable polymers, which act 
as a new bioengineered cardiovascular prosthesis. Tabata et 
al. has been studied type l collagen can act as a reservoir of 
basic fibroblastic growth factor. Chain et al, the expansion of 
biodegradable porous scaffolding for tissue engineering has 
also been studied [52]. 
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Table 5: List of some marketed products of microsponge drug delivery system 
Product Name Manufacturer Advantages 
Carac Cream Dermik Laboratories, 
Inc. Berwyn , PA 
19312 USA 
Carac creams contain 0.5% fl luorouracil; Patented porous microsphere 
with 0.35% was included in the methyl methacrylate / glycol dimethacrylate 
cross polymers and dimethicon. Factors are the topical prescription product 
for treatment of actinic keratosis (AK), which is due to the condition of 
normal pre-cancerous skin, due to which the sun is caused by instability 
[26]. 
Retin-A-Micro Ortho-McNeil 
Pharmaceutical, Inc. 
In a retin-A-Micro 0.1% and 0.04% tretinoin, a patent was trapped in porous 
microsphere, which included active ingredient in aqueous gel, methyl 
methacrylate / glycol dimethacrylate cross-polymer to include traitinoin. 
This formulation is used for topical treatment of acne vulgaris [21]. 
Salicylic Peel 20 & 
30 
Biophora Salicylic acid 20%, Micro-sponge technology has excellent exemption and is 
used for skin resistant to more resistant skin types. It will appreciably 
recover pigmentation, fine lines and acne concerns. Salicylic acid runs 
effortlessly throughout Pierce, while reducing inflammation they are taken 
out. This treatment effectively protects acne from the amazingly smooth and 
clear skin texture [11]. 
Line Eliminator Dual 
Retinol Facial 
Treatment. 
Avon Two-system wrinkle action, both immediate and timely released. Obviously, 
fine lines, wrinkles, and skin color seem to be related to aging [26]. 
Micro Peel Plus /Acne 
Peel 
Biomedic The MicroPeel ® Plus procedure stimulate cell turn in excess of from first to 
last the application of salicylic acid in the form of microcrystals using MDS. 
Micro peel Plus forcefully releases the skin of all dead cells by defeat other 
surface chemical peels, while not harming the skin [21]. 
Retinol cream, Retinol 
15 Night cream 
Biomedic, Sothys A night-time treatment cream with microsponge technology using pure 
static, a stable formula of vitamin A. Continuous use of retinol 15 will result 
in fine lines and wrinkles, a noticeable improvement in the skin 
discolorations due to aging, and enhanced skin smoothness [26]. 
Lactrex™ 12% 
Moisturizing Cream 
(Pentewar RS et al., 
2014). 
SDR Pharmaceuticals, 
Inc., Andover , NJ , 
U.S.A. 07821 
Microsponge® technology has been included for effortless application and 
for long lasting moisturization. Lactrex ™ includes water and glycerin, a 
natural humectants help moisturize soft and dry, flaky, broken skin [52]. 
EpiQuin Micro SkinMedica Inc Microsponges continuously release these ingredients in the skin throughout 
the day. It provides skin with constant contact of hydroquinone and retinol 
over time, thereby reducing skin irritation. EpiQuin Micro A Recipe 
Moisturizing Fading Cream That Reduces Effect. These conditions are 
known as melasma, after inflammatory hyper pagmentation or solar 
lactagens. Also help in age spots, sun spots and facial discoloration [18]. 
Oil free matte block 
spf20 
Dermalogica This imperceptible oil-free sunscreen shields the skin from damaging UV 
sun rays while controlling oil production, giving a healthy matte finish. 
Designed with micro-sponge technology, the oil-free matte block absorbs oil 
and can prevent brightness without any powder residues [32] 
Sportscream RS and 
XS 
Embil Pharmaceutical 
Co. 
Ltd. 
For the management of musculoskeletal conditions, timely analgesic anti-
inflammatory and counter-hibernation activated in a Microscope delivery 
system (MDS) [53]. 
Oil Control Lotion Fountain Cosmetics With feature-load lotion prepared with oil-absorbing micro-sponge 
technology, eliminate the shine for hours. Complex shoulder swelling and 
stiffness to promote antibiotic skin retention therapy naturally Acne-prone, 
oily skin condition [40]. 
Ultra Guard Scott Paper compony Microsponges system, which includes dimethicone to help protect a child's 
skin with diaper rash. The new wipes contain a skin protector that helps 
keep moisture and trouble from the skin of the baby. The solution is free of 
alcohol, is hypoallergenic and contains dimethicone, a component found in 
baby cream, lotions and skin protector [41]. 
Aramis fragrances Aramis Inc. Microsponge formulation are available in the form of ultra-light powder, it 
can easily take the aroma oil because of its suitable size. While the free-wide 
powder maintains the feature where the release is controlled due to 
moisture and temperature [52]. 
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Table 6: PATENT INFORMATION 
September 1, 1987 Won R  of Advanced 
Polymer Systems, Inc.  
Received (US Patent 4,690,825) for Developing method to deliver an 
active ingredient by controlled time release using a novel delivery 
vehicle that can be prepared by a process utilizing the active ingredient 
as a porogen [53] 
September 8, 1992, Won R of Advanced Polymer 
Systems, In 
Received (US Patent 5,145,675) for developing a two-step method for 
the preparation of controlled release formulation [53]. 
July 23, 2006 Advanced Polymer Systems, 
Inc. and subsidiaries ("APS" 
or the "Company") 
Use MDS and related proprietary technologies to increase the 
effectiveness of security, beauty and topical prescriptions on personal 
care products such as counter ("OTC") and vitamin-A, traitinos and 5-
fluoraurus. . 
 
Dean JR et al, US Patent Number Received 4863856 There 
are highly cross-linked collagen metrics for the development 
of weighted collagen microsponges, which is intended for use 
in fusion organisms in the reactor system. The pore structure 
of the surface of microsponges is an open dose for the size 
and size of the pore, which is suitable for stabilizing a range 
of bio active material. 
3. CONCLUSIONS 
The Microsponges Drug Delivery System is a novel strategy 
that regulates the delivery rate of active agents with less skin 
irritation and continues the drug during extended periods of 
time. They are stable over a wide range of pH (1-11) and 
temperature (up to 130º C), and are compatible with most 
vehicles and materials. Because the average pore diameter is 
less than 0.25 pm, bacteria cannot penetrate these structures 
and reach their contents; Therefore, they are self-sterilizing 
and do not need any preservatives. Topical MDS can be used 
to prevent drug penetration into the subcutaneous layer and 
reduce skin irritancy. In doing so, this system can provide 
maximum effectiveness for therapeutic active agents, 
reducing their irritability and increasing their safety, 
increase product stability in a skilled and novel way. Apart 
from this, MDS can also be cost effective for the use of 
cosmetic and MDS offering high drug loading efficiency 
compared to other conventional dosage forms. Thus 
microsponge approach can be successfully utilized to 
improve the pharmacokinetics and therapeutic efficacy, 
simultaneously reducing irritability and toxicity of various 
highly potent drugs. 
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